NYU’s Neil Vasan departs as acting chair of FDA’s cancer drug advisory panelnews2026-07-29T17:02:49+00:00July 29th, 2026|Endpoints News|
Atea’s hep C pill equal to Gilead’s; AbCellera inks second deal in two monthsnews2026-07-29T15:17:35+00:00July 29th, 2026|Endpoints News|
Two biotechs sign reverse mergers to advance I&I drug, BTK inhibitornews2026-07-29T14:46:38+00:00July 29th, 2026|Endpoints News|
AI doctor Doctronic buys Summer Health, expanding into pediatric carenews2026-07-29T12:00:44+00:00July 29th, 2026|Endpoints News|
Former Recursion CEO Chris Gibson joins Dimension as operating partnernews2026-07-29T11:00:37+00:00July 29th, 2026|Endpoints News|
Leqembi records best quarter since launch as Biogen raises guidancenews2026-07-29T10:00:26+00:00July 29th, 2026|Endpoints News|
FDA reminds investors about the risks of advisory panelsnews2026-07-28T19:08:10+00:00July 28th, 2026|Endpoints News|
FDA offers updated guidance for generics of weight loss blockbustersnews2026-07-28T18:08:40+00:00July 28th, 2026|Endpoints News|
Oak Hill Bio merges with RA Capital SPAC; InnoCare’s TYK2 drug hits in Phase 3news2026-07-28T15:17:47+00:00July 28th, 2026|Endpoints News|